MTAR Technologies Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/319kixxlw692qj6sxusimkz8.pdf

Key Takeaways


Revenue & Margin Performance

Srinivas Reddy: "We strongly believe that the company is at an inflection point, with each of our key business verticals positioned for next phase of growth."

Order Book & Demand Visibility

Srinivas Reddy: "So, the best part of our order book, it's not like an order book which has to be executed over 5 years or 10 years, it's all short cycle. Some are within 1 year, some are within 6 months, some are within 2 months, some are within 1 and a half 2 years. So, it is something that continuous order book is going to happen."

Civil Nuclear: The Inflection Point

Srinivas Reddy: "We believe civil nuclear vertical has transitioned to a more consistent and sustainable growth trajectory with substantially reduced cyclicality compared to the past."

Clean Energy & Fuel Cells


Working Capital & Balance Sheet

Gunneswara Rao: "We don't want to affect the margins in the company. As long as it is margins are better and everything is good, then only we can take any of the actions, but whatever we have done is organically we are able to reduce now."

Capex, Expansion & Return Metrics


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth80% YoY; management "pretty confident to do better" and may upgradeFY27; upgrade assessed by end of next quarter
EBITDA margin24% ±100 bpsFY27
Closing order bookRobust ₹5,000 crores (already exceeded with ₹5,143 cr + ₹800 cr incremental orders received today)FY27 year-end
Working capital daysSustain below 100 daysFY27 year-end
Receivables + inventory daysSustain around 200–220 daysFY27
Fuel cell Phase 2To be commissionedSeptember–October 2026
Fuel cell Phase 3Multifold capacity expansion to be commissioned; ramp-up from AprilMarch 2027
Oil & Gas facilityWill be operationalOctober 2026
Aerospace & Defense revenueDouble revenuesFY27
ROCEReach 23%Next year (FY28)
Capex~₹500 croresFY27 and FY28
Refurbishment order inflowsAnother ₹130–140 crores expectedCurrent quarter (Q2 FY27)
Nuclear L1 order (~₹130 cr)Expected to be receivedCurrent quarter (Q2 FY27)

Key Metrics

MetricQ1 FY27
Revenue₹360.7 cr, +130.4% YoY
EBITDA₹85.1 cr, +199.7% YoY
EBITDA margin23.6%, in line with annual guidance of 24% ±100 bps; 20.11% in Q4 FY26
Profit before tax₹67.4 cr, +355% YoY
Profit after tax₹50.2 cr, +364.5% YoY
PAT margin13.92%, vs 6.9% in Q1 FY26
Gross margin45.61%, vs 47.65% in Q1 FY26; decline due to revenue mix
ROCE17.2%, vs 11.4% prior year; expected to reach 23% next year
Cash flow from operations₹247.69 cr, vs ₹191.66 cr in Q1 FY26
Working capital days59 days, vs 172 days in full FY26; year-end target revised to ~100 days from 150–175 days
Net debt~₹20–30 cr, after adjusting ₹379 cr investments against ₹423.6 cr gross debt
Closing order book₹5,143 cr at quarter-end; additional ₹800 cr orders received on 30 July 2026
Nuclear order book₹684 cr as of Q1; expecting additional ₹130–140 cr this quarter, total ~₹815 cr
Capex incurred in Q1~₹35 cr spent; ₹80 cr capitalized from earlier capital WIP
FY27 revenue growth guidance80% YoY; management confident of doing better
FY27 EBITDA margin guidance24% ±100 bps; management confident of doing better